VAERS 2021 Database www.vaers.hhs.gov

Main Page | All 2021 Deaths | Videos
VAERS Updated: 11/12/2021
** VAERS DATABASE Last updated: November 12, 2021**
PLEASE CHECK BACK SOON
Download the files above while you wait.







Manufacturers

Total Manufacturer
199,106MODERNA
36,710JANSSEN
5,381PFIZER\BIONTECH
2,555GLAXOSMITHKLINE BIOLOGICALS
1,469UNKNOWN MANUFACTURER
897MERCK & CO. INC.
627SEQIRUS, INC.
112DYNAVAX TECHNOLOGIES CORPORATION
91SANOFI PASTEUR
75NOVARTIS VACCINES AND DIAGNOSTICS
40EMERGENT BIOSOLUTIONS
14PAXVAX
12TEVA PHARMACEUTICALS
12PROTEIN SCIENCES CORPORATION
9PFIZER\WYETH
4BERNA BIOTECH, LTD.
4SMITHKLINE BEECHAM
3INTERCELL AG
1MEDIMMUNE VACCINES, INC.
1CSL LIMITED

COVID19 Lot Number

VAX LOT Total
2S9CL7,949
7,473
2,547
1,506
1,187
1,051
1,049
s0294561,043
866
IMM209861
816
UT7065MA766
657
579
U62828AA563
557
538
U6737AA516
515
S034636506
4F472471
458
P100253275449
444
276563436
429
418
4BH32414
MENVEO404
PP9L5362
UJ446AA337
319
306
290
271
49TM3270
R1B252M253
4F472179
933622147
C5763AA144
CW3116134
3Y7NL126
UNK114
113
ARBA141A105
104
103
96
300057A90
79
1F4EB73
R1B743M62
56
UJ090AA55
51
UH894AB46
45
UNK44
UNK42
42
EJ168638
Unknown36
35
34
32
32
26
el128424
24
A115A22
22
EN620222
21
UNK20
20
19
Z127A19
19
17
JEV18K95E15
12
111798PI12
10
A739088
No batch number8
3333324181078
6
6
TAR356
5
5
U6935AA5
UNK5
4
unknown4
3
2
55RB72
2
2
2
2
2
U7124AA2
JEV18A68E2
2
ABYB05BA1
1
1
1
1
AMVA436A1
1
1
TJ3521
A130A; VIS give1
1
U7140BB1
1
1
SP UP016AA1
1
1808P08802/ESV01
037K20A300,947
EL1284288,578
57,766
1,432

Incidents per State

State Total
82,750
CA62,821
FL38,209
TX36,512
NY34,921
PA23,646
IN23,622
IL20,597
MI19,590
OH19,426
NJ18,413
NC16,769
GA15,932
WA15,351
VA15,234
MA14,876
AZ14,206
MN12,940
MD12,656
CO11,908
WI11,425
MO10,240
TN9,685
OR8,768
KY8,437
CT8,300
SC6,700
OK6,293
AL5,692
LA5,025
IA4,825
KS4,821
UT4,637
NV4,374
NM3,967
AR3,807
ME3,161
NH3,096
NE2,918
MS2,859
ID2,785
WV2,469
HI2,459
PR2,417
MT2,414
RI2,076
DE1,868
AK1,830
VT1,734
DC1,715
ND1,388
SD1,269
WY866
GU118
VI69
AS47
MP29
MH8
XB6
FM4
QM3
XV2
XL1

ID: 1811671
Sex: F
Age:
State: MO

Vax Date: 04/26/2021
Onset Date: 04/27/2021
Rec V Date: 10/23/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 037K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Dysphagia, Epiglottitis

Symptoms: My arm and underarm are killing me; My arm and underarm are killing me; I also have a fever; This is a spontaneous report from a contactable consumer, the patient. A 49-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 26Apr2021 at 16:00 (at the age of 49-years-old) as a single dose for COVID-19 immunisation. Medical history included penicillin allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included ibuprofen (MANUFACTURER UNKNOWN) for unknown indication on an unknown date and unknown if ongoing. On 27Apr2021 at 02:00, the patient's arm and underarm were killing. The patient also had a fever. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events patient arm and underarm were killing and fever was not recovered at the time of this report. No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds: IBUPROFEN

Current Illness:

ID: 1811672
Sex: F
Age:
State: MI

Vax Date: 04/24/2021
Onset Date: 04/24/2021
Rec V Date: 10/23/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025L20A
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Anxiety, Dyspnoea

Symptoms: Severe headache almost to a migraine on day 2 and 3.; Severe headache almost to a migraine on day 2 and 3.; Extreme tiredness on first day; This is a spontaneous report from a contactable consumer, the patient. A 49-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EL9261) via an unspecified route of administration in the left arm on 24Apr2021 at 13:00 (at the age of 49-years-old) as a single dose for COVID-19 immunisation. Medical history included polycystic ovarian syndrome (PCOS), high cholesterol, depression, hypothyroidism and lactose intolerance. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient received unspecified concomitant medications and it was reported as too many to be listed. On 24Apr2021, on the first day of vaccination, the patient experienced extreme tiredness. On 25Apr2021 and 26Apr2021, on days 2 and 3, the patient had severe headache almost to a migraine. The events did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events extreme tiredness and severe headache almost to a migraine was resolving at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1811673
Sex: F
Age:
State: CA

Vax Date: 03/15/2021
Onset Date:
Rec V Date: 10/23/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot: EL1284
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Chest discomfort, Dysphagia, Pain in extremity, Visual impairment

Symptoms: Stick/sore neck; Stick/sore neck; This is a spontaneous report from a contactable consumer, the patient. A 40-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6208) via an unspecified route of administration in the left arm on 15Mar2021 at 12:30 (at the age of 40-years-old) as a single dose and received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8727) via an unspecified route of administration in the left arm on 05Apr2021 at 11:30 (at the age of 40-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included zinc (MANUFACTURER UNKNOWN), melatonin (MANUFACTURER UNKNOWN), colecalciferol (VIT D), ascorbic acid (VIT C) and probiotics (MANUFACTURER UNKNOWN); all for unknown indications from unknown dates and unknown if ongoing. On an unknown date in 2021, the patient experienced stick/sore neck after the first shot and it went away, and then a stick/sore neck after the second shot that the patient still had at the time of reporting. It got much worse with alcohol consumption. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events stick/sore neck was not resolved at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: ZINC; MELATONIN; VIT D [COLECALCIFEROL]; VIT C

Current Illness:

ID: 1811674
Sex: F
Age:
State: WA

Vax Date: 04/23/2021
Onset Date: 04/24/2021
Rec V Date: 10/23/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: unknown
Dose Series: UNK
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Dizziness, Fatigue, Mobility decreased

Symptoms: Pain in the injection site; Sore throat; Fatigue; Headache; Worsened tinnitus; dizziness; This is a spontaneous report from a contactable consumer, the patient. A 34-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0162) via an unspecified route of administration in the arm left on 23Apr2021 at 12:00 (at the age of 34-years-old) as a single dose for COVID-19 immunisation. Medical history included tinnitus, temporomandibular joint disorder and bipolar disorder. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included amoxicillin (MANUFACTURER UNKNOWN) for urinary tract infection from an unknown date and unknown if ongoing and ferrous sulfate/folic acid/zinc (PRENATAL) for unknown indication from an unknown date and unknown if ongoing. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 24Apr2021 the patient experienced pain in the injection site, sore throat, fatigue, headache, worsened tinnitus and dizziness. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the event. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events pain in the injection site, sore throat, fatigue, headache, worsened tinnitus and dizziness were resolving at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: AMOXICILLIN; PRENATAL [FERROUS SULFATE;FOLIC ACID;ZINC]

Current Illness:

ID: 1811675
Sex: M
Age:
State: KS

Vax Date: 04/26/2021
Onset Date: 04/27/2021
Rec V Date: 10/23/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data: Test Date: 20210427; Test Name: Body temperature; Result Unstructured Data: Test Result:101.5

Allergies:

Symptom List: Injection site erythema, Injection site pruritus, Injection site swelling, Injection site warmth

Symptoms: After having the second shot, 24 hours later I'm running a 101.5 fever; chills; achiness; This is a spontaneous report from a contactable consumer, the patient. A 56-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 26Apr2021 at 13:30 (at the age of 56-years-old) as a single dose for COVID-19 immunisation. Medical history included penicillin allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included escitalopram oxalate (LEXAPRO) and bupropion hydrochloride (WELLBUTRIN); both for an unknown indication from an unknown date and unknown if ongoing. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 05Apr2021 at 13:30 (at the age of 56-years-old) as a single dose for COVID-19 immunisation. On 27Apr2021, 24 hours later, the patient experienced fever of 101.5(unspecified units), along with chills and achiness. On 27Apr2021, the patient checked body temperature and the result was 101.5(unspecified units). The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events 101.5 fever along with chills and achiness were not resolved at the time of this report. No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds: LEXAPRO; WELLBUTRIN

Current Illness:

ID: 1811676
Sex: F
Age:
State:

Vax Date: 04/01/2021
Onset Date: 04/01/2021
Rec V Date: 10/23/2021
Hospital:

Vax Type: FLUC4
Manufacturer: SEQIRUS, INC.
Vax Name: INFLUENZA (SEASONAL) (FLUCELVAX QUADRIVALENT)
Lot: 276563
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Chills, Confusional state, Eye inflammation, Headache, Laboratory test

Symptoms: Flu like symptoms; Severe body aches; Chills; Low grade fever,; Lingering headache; This is a spontaneous report from a non-contactable consumer, the patient and also from a contactable consumer. An adult non-pregnant female patient of unspecified age received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on an unknown date in Apr2021 as a single dose for COVID-19 immunisation. Medical history and concomitant medication were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. It was unknown whether the patient had received any other vaccines within four weeks prior to the COVID vaccine. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on an unknown date as a single dose for COVID-19 immunisation. On an unknown date in Apr2021, the patient experienced flu like symptoms, severe body aches, chills, low grade fever and lingering headache. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events flu like symptoms, severe body aches, chills, low grade fever and lingering headache was unknown at the time of this report. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds:

Current Illness:

ID: 1811677
Sex: F
Age:
State: NC

Vax Date: 04/21/2021
Onset Date: 04/21/2021
Rec V Date: 10/23/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Pyrexia, White blood cell count decreased

Symptoms: Nausea; Mild vomiting; Diarrhea; Moderate abdominal pain; Sweating; This is a spontaneous report from a contactable consumer, the patient. A 47-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8736) via an unspecified route of administration in the left arm on 21Apr2021 at 11:00 (at the age of 47-years-old) as a single dose for COVID-19 immunisation. Medical history included allergy to penicillin and gluten. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included fexofenadine hydrochloride (ALLEGRA), pseudoephedrine hydrochloride (SUDAFED), ethinylestradiol/ levonorgestrel (CAMRESE LO) and multi-vitamin (MANUFACTURER UKNOWN); all from an unknown date for an unknown indication and unknown if ongoing. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8733) via an unspecified route of administration in left arm on 31Mar2021 at 10:00 (at the age of 47-years-old) as a single dose for COVID-19 immunisation. On 21Apr2021 at 23:30, the patient experienced nausea, mild vomiting, diarrhea, moderate abdominal pain and sweating-no fever. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events nausea, mild vomiting, diarrhea, moderate abdominal pain and sweating were resolving at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: ALLEGRA; SUDAFED [PSEUDOEPHEDRINE HYDROCHLORIDE]; CAMRESE LO

Current Illness:

ID: 1811678
Sex: M
Age:
State: AZ

Vax Date: 04/21/2021
Onset Date: 04/22/2021
Rec V Date: 10/23/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: UNK
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Pharyngeal swelling

Symptoms: Severe soreness in right arm. Difficult to move past parallel. Had to continue movement to loosen up.; This is a spontaneous report from a contactable consumer, the patient. A 58-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: 59267-1000-02) via an unspecified route of administration in the right arm on 21Apr2021 at 16:15 (at the age of 58-years-old) as a single dose for COVID-19 immunisation. Medical history included pollen allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included fluticasone propionate (FLONASE) and multivitamin (MANUFACTURER UNKNOWN) both were taken for an unknown indication from an unknown date and unknown if ongoing. On 22Apr2021 at 06:30, the patient experienced severe soreness in right arm, difficult to move past parallel where he had to continue movement to loosen up. He also reported that he never experienced such soreness after an immunization in his life. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event severe soreness in right arm and difficult to move past parallel, had to continue movement to loosen up was not recovered at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: FLONASE [FLUTICASONE PROPIONATE]

Current Illness:

ID: 1811679
Sex: F
Age:
State: NY

Vax Date: 04/22/2021
Onset Date: 04/01/2021
Rec V Date: 10/23/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Abdominal pain, Chills, Sleep disorder

Symptoms: "I" developed a rash on the 4th day and then hives. The hives woke me up at 2am on 4/27.; "I" developed a rash on the 4th day; "I" experienced chills and aches for 3.5 to 4 days; "I" experienced chills and aches for 3.5 to 4 days; Soreness in left "my" armpit; This is a spontaneous report from a contactable consumer, the patient. A 42-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0164) via an unspecified route of administration in the left arm on 22Apr2021 at 12:30 (at the age of 42-years-old) as a single dose for COVID-19 immunisation. The medical history included moles removed, benign thyroid nodule and half of thyroid removed. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. The concomitant medications included levothyroxine sodium (UNITHROID), ascorbic acid (VITAMIN C), multivitamin(unspecified), sambucus nigra fruit (ELDERBERRY) and vitamin d nos (VITAMIN D); all for an unknown indications from unknown dates and unknown if ongoing. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 01Apr2021 at 12:15 (at the age of 42-years-old) as a single dose for COVID-19 immunisation. On an unknown date in Apr2021, the patient experienced chills and aches for 3.5 to 4 days, including soreness in left armpit. On 26Apr2021, the 4th day the patient developed a rash. On 27Apr2021 at 02:00, the hives woke the patient up. The adverse events resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as a result of hives included treatment with diphenhydramine hydrochloride (BENADRYL) and cetirizine hydrochloride (ZYRTEC). Since, the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events chills and aches were resolved on unknown date in Apr2021, while the clinical outcome of the event soreness in left armpit was unknown at the time of this report. The clinical outcome of the events rash and hives were not resolved at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: UNITHROID; VITAMIN C [ASCORBIC ACID]; VITAMIN D [VITAMIN D NOS]; ELDERBERRY [SAMBUCUS NIGRA FRUIT]

Current Illness:

ID: 1811680
Sex: M
Age:
State: WA

Vax Date: 04/25/2021
Onset Date: 04/26/2021
Rec V Date: 10/23/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J201A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Diarrhoea, Nasal congestion

Symptoms: 36 hours after my shot I experience a mild frontal headache; This is a spontaneous report from a contactable consumer, the patient. A 57-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EER8730) via an unspecified route of administration in the right arm on 25Apr2021 at 12:30 (at the age of 57-year-old), as a single dose for COVID-19 immunisation. The patient had no medical history and had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. The patient did not receive any concomitant medications. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8737) via an unspecified route of administration in the left arm on 04Apr2021 at 12:00 (at the age of 57-year-old), as a single dose for COVID-19 immunisation. On 26Apr2021 at 00:00, 36 hours after shot, the patient experienced mild frontal headache which lasted most of the day until after dinner. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the event. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event mild frontal headache was resolved on an unknown date in Apr2021. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1811681
Sex: F
Age:
State: FL

Vax Date: 04/19/2021
Onset Date: 04/19/2021
Rec V Date: 10/23/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Vaccination site erythema, Vaccination site pruritus, Vaccination site swelling

Symptoms: Menstrual spotting following the first shot of the vaccine; This is a spontaneous report from a non-contactable consumer, the patient. A 40-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Unknown) via an unspecified route of administration in the right arm on 19Apr2021 at 09:30 (at the age of 40-years-old) as a single dose for COVID-19 immunisation. The patient had no other medical history. The patient had no allergies to medications, food, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient did not receive any concomitant medications. On 19Apr2021, the patient experienced menstrual spotting following the first shot of the vaccine. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the event. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event menstrual spotting following the first shot of the vaccine was recovering at the time of this report. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds:

Current Illness:

ID: 1811682
Sex: F
Age:
State: MA

Vax Date: 04/14/2021
Onset Date: 04/15/2021
Rec V Date: 10/23/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039k20a
Dose Series: 1
Vax Route: SYR
Vax Site: RA

Lab Data: Test Date: 20210419; Test Name: RT PCR; Test Result: Negative

Allergies:

Symptom List: Rash, Urticaria

Symptoms: 72 hours after receiving dose, I woke up to extremely loud tinnitus; unable to sleep; Persistent random joint and muscle pain has been present since 18 hours post-dose.; Persistent random joint and muscle pain has been present since 18 hours post-dose.; This is a spontaneous report from a contactable consumer, the patient. A 50-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0158) via an unspecified route of administration in the left arm on 14Apr2021 at 15:30 (at the age of 50-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not take any concomitant medication. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6203) via an unspecified route of administration in the left arm on 03Mar2021 at 17:45 (at the age of 50-year-old) as a single dose for COVID-19 immunisation. On 15Apr2021 at 09:30, 18 hours post-dose, the patient had persistent random joint and muscle pain. On 17Apr2021 at 15:30, 72 hours after receiving dose, the patient woke up to extremely loud tinnitus, unable to sleep and tinnitus had been constant ever since. On 19Apr2021, the patient underwent RT PCR test and the result was Negative. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had been tested for COVID-19. The clinical outcome of the events persistent random joint and muscle pain, woke up to extremely loud tinnitus and unable to sleep was not resolved at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1811683
Sex: F
Age:
State: TN

Vax Date: 04/06/2021
Onset Date: 04/06/2021
Rec V Date: 10/23/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Blood pressure decreased, Chest pain, Chills, Confusional state, Decreased appetite

Symptoms: Extreme leg, hip foot pain; Extreme leg, hip foot pain; Extreme leg, hip foot pain; Muscle aches that moved uno and down; Tingling; Burning sensation in foot, toes; Now have several bumps appear near a tick bite from last summer; Tennis ball size swelling in arm; Headache; Extreme, deep body ache; Chills; Lethargy; This is a spontaneous report from a contactable consumer, the patient. A 63-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP7533) via an unspecified route of administration in the left arm on 06Apr2021 at 10:45 (at the age of 63-years-old) as a single dose for COVID-19 immunisation. The patient's medical history included suspected COVID-19 on Jan2020. The patient did not have any known allergies. Prior to the vaccination, the patient was diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. Concomitant medications included ascorbic acid (VITAMIN C), vitamin b complex (VITAMIN B), tocopherol (VITAMIN E), vitamin D nos (VITAMIN D), magnesium glycinate (MANUFACTURER UNKNOWN) and collagen (MANUFACTURER UNKNOWN); all for an unknown indication from an unknown date and unknown if ongoing. On 06Apr2021 at 22:00, the patient experienced tennis ball size swelling in arm, headache, extreme, deep body ache, chills, lethargy first 3 days then was slowly subsiding, had muscle aches that moved up and down, tingling, burning sensation in foot, toes that lasted about a week then subsiding and also had several bumps appear near a tick bite from last summer. On 16Apr2021, 10 days later, the patient had extreme leg, hip foot pain. It was reported that the patient walks about 5 miles a day, eat a vegetarian diet, take vitamins & know body well, the patient rarely caught colds/ flu but the patient believe that she had COVID-19 in Jan 2020. It was reported that the patient was concerned about taking a second dose of vaccination after the pronounced reaction to 1st dose of COVID vaccine injection. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events swelling in the arm, headache, extreme, deep body ache, chills, lethargy and extreme leg, hip foot pain, had muscle aches that moved up and down, tingling, burning sensation in foot, toes and now have several bumps were recovering at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: VITAMIN C [ASCORBIC ACID]; VITAMIN B [VITAMIN B COMPLEX]; VITAMIN E [TOCOPHEROL]; VITAMIN D [VITAMIN D NOS]; MAGNESIUM GLYCINATE; COLLAGEN

Current Illness:

ID: 1811684
Sex: F
Age:
State: CA

Vax Date: 04/19/2021
Onset Date: 04/19/2021
Rec V Date: 10/23/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20-2A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data: Test Date: 20210419; Test Name: Body temperature; Result Unstructured Data: Test Result:103 Units:[degF]; Comments: Fever of 103F

Allergies:

Symptom List: Dyspnoea, Fatigue, Feeling abnormal, Head discomfort, Headache

Symptoms: Fever of 103F; Body aches; Extreme Fatigue; Extreme itchiness on face and neck; This is a spontaneous report from a non-contactable consumer, the patient. A 35-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0158) via an unspecified route of administration in the left arm on 19Apr2021 at 09:15 (at the age of 34-year-old) as a single dose for COVID-19 immunisation. The patient had just seasonal tree pollen allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient did not receive concomitant medications. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8732) via an unspecified route of administration in the left arm on 29Mar2021 at 09:15 (at the age of 34-year-old) as a single dose for COVID-19 immunisation. On 19Apr2021 at 19:00, the patient experienced fever of 103F, body aches, extreme fatigue, and extreme itchiness on face and neck with no airway compromise. On the same day, the patient underwent body temperature test and the result was 103 degrees Fahrenheit. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events fever of 103F, body aches, extreme fatigue, and extreme itchiness on face and neck with no airway compromise was not recovered at the time of this report. No follow-up attempts are possible. No further information is expected.

Other Meds:

Current Illness:

ID: 1811685
Sex: F
Age:
State: MA

Vax Date: 04/07/2021
Onset Date: 04/07/2021
Rec V Date: 10/23/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Heart rate decreased, Heart rate increased, Hypertension, Injection site pain, Musculoskeletal chest pain

Symptoms: Weird feeling in the left side of my mouth, felt like i just left the dentist's; Sore arm; 2 day fever; Muscle soreness; Fatigue; Sore throat; Upset stomach; Diarrhea; Sick for 4 days; This is a spontaneous report from a non-contactable consumer, the patient. A 47-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8737) via an unspecified route of administration in the left arm on 07Apr2021 at 10:00 (at the age of 47-years-old) as a single dose for COVID-19 immunisation. Medical history included gestational thrombocytopenia. The patient had no known allergies to medications, food or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient did not receive any other medications in two weeks of vaccination. On 07Apr2021 at 00:00, the patient experienced weird feeling in the left side of her mouth, felt like she just left the dentist's. The patient had gestational thrombocytopenia with 3 pregnancies so she was concerned, especially since the center did not give her a side effects sheet. Other than that sore arm, 2 days fever, muscle soreness, fatigue, sore throat, upset stomach, diarrhea, and was sick for 4 days, probiotics helped. The patient would take second dose but was very apprehensive, figured she would chime in as her past issues with the thrombocytopenia. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of events weird feeling in the left side of her mouth, felt like she just left the dentist's, sore arm, 2 days fever, muscle soreness, fatigue, and sore throat. Therapeutic measures were taken as a result of events upset stomach, diarrhea, and was sick for 4 days, which included treatment with probiotics which helped. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events weird feeling in the left side of her mouth, felt like she just left the dentist's, sore arm, muscle soreness, fatigue, sore throat, upset stomach, and diarrhea were recovered on an unknown date in Apr2021. The clinical outcome of the events 2 days fever was recovered on 09Apr2021 and sick for 4 days was recovered on 11Apr2021. No follow-up attempts are possible. No further information is expected.

Other Meds:

Current Illness:

ID: 1811686
Sex: F
Age:
State: CA

Vax Date: 04/18/2021
Onset Date: 04/01/2021
Rec V Date: 10/23/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Nausea, Pain, Pain in extremity, Paraesthesia oral, Pyrexia

Symptoms: Intermittent pain in right ear; This is a spontaneous report from a contactable consumer, the patient. A female patient of an unknown age received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8734) via an unspecified route of administration in the right arm on 18Apr2021 as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On an unknown date in Apr2021, the patient experienced intermittent pain in right ear. Therapeutic measures were not taken as a result of the event. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event intermittent pain in right ear was unknown at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1811687
Sex: F
Age:
State: NC

Vax Date: 04/26/2021
Onset Date: 04/27/2021
Rec V Date: 10/23/2021
Hospital:

Vax Type: DTAPHEPBIP
Manufacturer: GLAXOSMITHKLINE BIOLOGICALS
Vax Name: DTAP + HEPB + IPV (PEDIARIX)
Lot:
Dose Series: UNK
Vax Route:
Vax Site: LG

Lab Data:

Allergies:

Symptom List: SARS-CoV-2 antibody test, SARS-CoV-2 test negative

Symptoms: Excessive swelling in L side cervical and supraclavicular lymph nodes; Excessive swelling in L side cervical and supraclavicular lymph nodes; Excessive swelling in L side cervical and supraclavicular lymph nodes with pain.; This is a spontaneous report from a contactable nurse, the patient. A 30-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EL3247) via an unspecified route of administration in the left arm on 26Apr2021 at 10:45 (at the age of 30-years-old) as a single dose for COVID-19 immunisation. The patient did not have any medical history. Prior to vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included unspecified OTC prenatals (MANUFACTURER UNKNOWN) from an unknown date for an unknown indication and unknown if ongoing. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EL3247) via an unspecified route of administration in the left arm on 07Apr2021 (at the age of 30-years-old) as a single dose for COVID-19 immunisation. The patient previously received morphine (MANUFACTURER UNKNOWN), tramadol (MANUFACTURER UNKNOWN) and codeine (MANUFACTURER UNKNOWN) on unknown dates for unknown indications and experienced drugs allergy. The patient did not receive other vaccines within four weeks prior to the vaccination. On 27Apr2021 at 20:30, the patient experienced excessive swelling in left side cervical and supraclavicular lymph nodes with pain. The events resulted in doctor or other healthcare professional office/clinic visit. It was unknown whether any therapeutic measures were taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events excessive swelling in left side cervical and supraclavicular lymph nodes with pain was unknown at the time of this time. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1811688
Sex: F
Age:
State: NC

Vax Date: 03/30/2021
Onset Date: 03/30/2021
Rec V Date: 10/23/2021
Hospital:

Vax Type: HIBV
Manufacturer: MERCK & CO. INC.
Vax Name: HIB (PEDVAXHIB)
Lot:
Dose Series: UNK
Vax Route:
Vax Site: LG

Lab Data:

Allergies:

Symptom List: Ear pain, Hypoaesthesia

Symptoms: Lack of energy; Nausea; Diarrhea; Stomach cramps; Cold sweats; This is a spontaneous report from a contactable consumer, the patient. A 62-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER 8733) via an unspecified route of administration in the right arm on 30Mar2021 at 15:00 (at the age of 62-years-old) as a single dose for COVID-19 immunisation. Medical history included rheumatoid arthritis (RA). Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications were not reported. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient previously took dextropropoxyphene hydrochloride (DARVON), codeine (MANUFACTURER UNKNOWN) and paracetamol/oxycodone hydrochloride/oxycodone terephthalate (PERCOCET) and experienced drug allergy. On 30Mar2021 at 20:00, the patient experienced lack of energy, nausea, diarrhea, stomach cramps and cold sweats. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events lack of energy, nausea, diarrhea, stomach cramps and cold sweats was resolved on an unknown date in 2021. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1811689
Sex: F
Age:
State: NV

Vax Date: 04/20/2021
Onset Date: 04/20/2021
Rec V Date: 10/23/2021
Hospital:

Vax Type: PNC13
Manufacturer: PFIZER\WYETH
Vax Name: PNEUMO (PREVNAR13)
Lot:
Dose Series: UNK
Vax Route:
Vax Site: LG

Lab Data:

Allergies:

Symptom List: Abdominal pain upper, Dizziness, Dysgeusia

Symptoms: Headache; Severe body pain all over in muscles; Severe body pain all over in muscles, joints; Severe body pain all over in muscles, joints, skin; Severe body pain all over in muscles, joints, skin, nails; Extremely cold; Sweating profusely; Neck pain; Arm pain; Chest pain; Chest pressure; Fatigue; Loss of appetite; This is a spontaneous report from a contactable consumer, the patient. A 45-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Unknown) via an unspecified route of administration in the left arm on 20Apr2021 at 16:00 (at the age of 45-years-old) as a single dose for COVID-19 immunisation. Medical history included chronic leukemia, epstein-barr, chronic fatigue and anxiety. The patient had known allergies to contrast. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient received unspecified concomitant medications for an unknown indication from an unknown date and unknown if ongoing. The patient previously received ciprofloxacin (MANUFACTURER UNKNOWN) and inosine (BIOXIN); both taken for unknown indications and experienced drug allergy. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Unknown) via an unspecified route of administration in the left arm on 30Mar2021 at 15:30 (at the age of 45-years-old) as a single dose for COVID-19 immunisation. On 20Apr2021 at 22:00, the patient experienced headache, sever body pain all over in muscles, joints, skin, nails, extremely cold, then sweating profusely, neck pain, arm pain, chest pain, chest pressure, fatigue and loss of appetite. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events headache, sever body pain all over in muscles, joints, skin, nails, extremely cold, sweating profusely, neck pain, arm pain, chest pain, chest pressure, fatigue and loss of appetite was resolved with sequelae on an unknown date in Apr2021. No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds:

Current Illness:

ID: 1811690
Sex: F
Age:
State: TX

Vax Date: 04/08/2021
Onset Date: 04/08/2021
Rec V Date: 10/23/2021
Hospital:

Vax Type: RV1
Manufacturer: GLAXOSMITHKLINE BIOLOGICALS
Vax Name: ROTAVIRUS (ROTARIX)
Lot:
Dose Series: 1
Vax Route: PO
Vax Site: MO

Lab Data:

Allergies:

Symptom List: Blood pressure increased, Chest discomfort, Heart rate increased

Symptoms: Headache; Dizziness; Fatigue; Nausea; Soreness/Possible (Left) Ovarian Cyst; Soreness/Possible (Left) Ovarian Cyst.; This is a spontaneous report from a contactable consumer, the patient. A 63-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8733) via an unspecified route of administration in the left arm on 08Apr2021 at 13:30(at the age of 63-years-old) as a single dose for COVID-19 immunisation. The medical history included hypertension, irritable bowel syndrome (IBS), anxiety and seasonal allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The concomitant medications included propranolol (MANUFACTURER UNKNOWN), ibuprofen (ADVIL) and ALIVE womens multi, all for unknown indications from unknown dates and unknown if ongoing. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6206) via an unspecified route of administration in the left arm on 18Mar2021 at 13:45 (at the age of 63-years-old) as a single dose for COVID-19 immunisation. On 08Apr2021 at 13:45, the patient experienced headache, dizziness, fatigue, nausea and soreness/possible (left) ovarian cyst. The adverse events did not result in doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the reported events. Since the vaccination, the patient had not been tested for COVID-19.The clinical outcome of the events headache, dizziness, fatigue, nausea and soreness/possible (left) ovarian cyst were not resolved at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: PROPRANOLOL; ADVIL [IBUPROFEN]

Current Illness:

ID: 1811691
Sex: F
Age:
State: MO

Vax Date: 04/07/2021
Onset Date: 04/09/2021
Rec V Date: 10/23/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot: Eh9899
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site erythema, Injection site pruritus, Injection site swelling, Lymph node pain, Lymphadenopathy

Symptoms: Very sore lymph nodes; Discomfort left armpit area extending under and toward breast area. Also sore right side, more severe left side. Lasted for about 1.5 weeks.; Discomfort even when not moving, discomfort when arms at sides.; This is a spontaneous report from a contactable healthcare professional, the patient. A 26-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 07Apr2021 at 11:00 (at the age of 26-years-old) as a single dose for COVID-19 immunisation. Medical history included occasional migraine and headaches. The patient had no known allergies. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included loratadine (MANUFACTURER UNKNOWN) for unknown indication from unknown date and unknown if ongoing. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 17Mar2021 at 11:15 (at the age of 26-years-old) as a single dose for COVID-19 immunisation. On 09Apr2021 at 08:00, the patient experienced very sore lymph nodes/discomfort left armpit area extending under and toward breast area. Also, sore right side, more severe left side which lasted for about 1.5 weeks. The patient had discomfort even when not moving and discomfort when arms at sides. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events very sore lymph nodes/discomfort left armpit area extending under and toward breast area, also sore right side, more severe left side, discomfort even when not moving, discomfort when arms at sides were resolved on an unknown date in Apr2021. No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds: LORATADINE

Current Illness:

ID: 1811692
Sex: M
Age:
State: TX

Vax Date: 04/24/2021
Onset Date: 04/25/2021
Rec V Date: 10/23/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Unevaluable event

Symptoms: Systemic adverse reactions (grade 3, defined as interfering with daily activity), including fatigue; Systemic adverse reactions (grade 3, defined as interfering with daily activity), including muscle pain; Systemic adverse reactions (grade 3, defined as interfering with daily activity), including chills; Systemic adverse reactions (grade 3, defined as interfering with daily activity), including injection site pain; This is a spontaneous report from a contactable consumer, the patient. A 32-year-old male patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8BS) via an unspecified route of administration in the right arm on 24Apr2021 at 14:00 (at the age of 32-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. The patient had no known allergies. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications were not reported. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP6955) via an unspecified route of administration in the right arm on 27Mar2021 at 16:45 (at the age of 31-years-old) as a single dose for COVID-19 immunisation. On 25Apr2021 at 10:00, the patient experienced systemic adverse reactions (grade 3, defined as interfering with daily activity), including fatigue, muscle pain, chills and injection site pain. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events fatigue, muscle pain, chills and injection site pain was resolving at the time of report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1811693
Sex: F
Age:
State: CA

Vax Date: 04/23/2021
Onset Date: 04/23/2021
Rec V Date: 10/23/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Chills, Dizziness, Injection site pain, Myalgia, Pyrexia

Symptoms: Tennis ball- sized painful lump underarm.; Tennis ball- sized painful lump underarm.; Stiff neck; Pain in shoulders; Pain in upper back; Insomnia; Sore arm at injection area; This is a spontaneous report from a contactable consumer, the patient. A 35-year-old female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ELV0171) via an unspecified route of administration in the left arm on 23Apr2021 at 17:00 (at the age of 35-years-old) as a single dose for COVID-19 immunisation. Medical history included polycystic ovarian syndrome (PCOS). The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included cyproterone acetate / ethinylestradiol (DIANE) for birth control, fluoxetine (MANUFACTURER UNKNOWN), bromazepam (MANUFACTURER UNKNOWN) and methocarbamol (ROBAXIN); for an unknown indication from unknown date and unknown if ongoing. The patient previously received the first dose BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EL9261) via an unspecified route of administration in the right arm on 26Mar2021 at 11:15 (at the age of 34-years-old) as a single dose for COVID-19 immunisation. On 23Apr2021 at 22:00, the patient experienced sore arm at injection area. On 24Apr2021 at 22:00, 24 hours after the vaccination, the patient experienced tennis ball- sized painful lump underarm. Then on 23Apr2021 at 22:00, the patient experienced stiff neck, pain in shoulders and upper back, and insomnia the following 3 days. The events did not result in doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care. Therapeutic measures were taken as a result of events and included treatment with ice packs, ibuprofen (MANUFACTURER UNKNOWN) and ketorolac (MANUFACTURER UNKNOWN). Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events sore arm at injection area, tennis ball- sized painful lump underarm, stiff neck, pain in shoulders and upper back and insomnia was resolving at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: FLUOXETINE; BROMAZEPAM; ROBAXIN; DIANE

Current Illness:

ID: 1811694
Sex: M
Age:
State:

Vax Date: 04/27/2021
Onset Date: 04/27/2021
Rec V Date: 10/23/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011L20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site pain, Pain

Symptoms: Tingling feeling on back of hands,part of forearms; This is a spontaneous report from a non-contactable consumer, the patient. A 44-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA Vaccine; Lot Number: EW0176) via an unspecified route of administration in the right arm on 27Apr2021 at 17:45 (at the age of 44-years-old) as a single dose for COVID-19 immunisation. Medical history included asthma and known allergies to penicillin. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included duloxetine (MANUFACTURER UNKNOWN), for an unknown indication from an unknown date and unknown if ongoing. The patient did not receive any other vaccine within four weeks prior to the COVID-19 vaccine. On 27Apr2021 at 18:15, the patient experienced tingling feeling on back of hands, part of forearms. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. No therapeutic measures were not taken as a result of the event. The clinical outcome of the event tingling feeling on back of hands, part of forearms was not recovered at the time of this report. No follow-up attempts are possible. No further information is expected.

Other Meds: DULOXETINE

Current Illness:

ID: 1811695
Sex: F
Age:
State: NC

Vax Date: 04/09/2021
Onset Date: 04/01/2021
Rec V Date: 10/23/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site pain, Menorrhagia

Symptoms: Swollen hands and feet; Tight sensation and discomfort in back of legs/ heaviness in my feet and lower legs; Swollen gland in right armpit; Nausea; Burning sensation in back; Pain in injection site; ''I'' have experienced tingling, tightness and heaviness in ''my'' feet and lower legs.; ''I'' also feel slightly off; Having loose stool; This is a spontaneous report from a contactable consumer, the patient. A 35-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP7533) via an unspecified route of administration in the left arm on 09Apr2021 (at the age of 35-years-old) as a single dose for COVID-19 immunisation. Medical history included known allergies to unknown form of anxiety medication. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccine within four weeks prior to the COVID-19 vaccine. Concomitant medications included ethinylestradiol/ norethisterone acetate (LOESTRIN), multivitamin (MANUFACTURER UNKNOWN) and loratadine (CLARITIN); all for an unknown indication from an unknown date and unknown if ongoing. On 11Apr2021, the patient experienced swollen gland in right armpit, nausea and burning sensation in back 3 days later. The patient experienced swollen hands and feet next day (12Apr2021), had tight sensation and discomfort in back of legs, pain in injection site for 2 days. For the last 2 weeks and at the time of reporting, the patient experienced tingling, tightness and heaviness in her feet and lower legs. She also felt slightly off and had loose stool. Therapeutic measures were not taken as a result of reported events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event pain in injection site was resolved on an unknown date in Apr2021, after a duration of 2 days; while that of the tight sensation and discomfort in back of legs/ heaviness in my feet and lower legs, tingling feet, swollen gland in right armpit, nausea, burning sensation in back, swollen hands and feet, also feel slightly off and had loose stool was not resolved at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: LOESTRIN; CLARITIN [LORATADINE]

Current Illness:

ID: 1811696
Sex: F
Age:
State: GA

Vax Date: 03/26/2021
Onset Date: 03/27/2021
Rec V Date: 10/23/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Arthralgia, Chills, Headache, Mobility decreased, Myalgia

Symptoms: Not adverse!! Advantageous!!! All my post COVID symptoms went away! Headaches diarrhea. Tiredness and fatigue/aches. All left after the FIRST vaccine. Then all my eczema on my feet and psoriasis on my scalp wentaway after vaccine 2!; This is a spontaneous report from a contactable consumer, the patient. A 52-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8727) via an unspecified route of administration in the arm left on 26Mar2021 at 14:30 (at the age of 52-years-old) and second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER9729) via an unspecified route of administration in the arm left on 16Apr2021 at 15:00 (at the age of 52-years-old) as a single dose for COVID-19 immunisation. Medical history reported as nothing related. Prior to the vaccination it was unknown whether the patient was diagnosed with COVID-19. Concomitant medications were not reported. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 27Mar2021 at 08:00, the patient reported not adverse!! but advantageous!!! all her post COVID symptoms went away, headaches diarrhea, tiredness and fatigue/aches, all left after the first vaccine. Then all her eczema on her feet and psoriasis on her scalp went away after vaccine 2!!! she feels amazing!! Great effects! she wasn't sure how to let this know and said this was the only way and asked to please ensure someone follows up on this and told it's a miracle of science!!. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event, not adverse!! Advantageous!!! all her post COVID symptoms went away! headaches diarrhea, tiredness and fatigue/aches, all left after the first vaccine, then all her eczema on her feet and psoriasis on her scalp went away after vaccine 2 was unknown at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1811697
Sex: M
Age:
State: PA

Vax Date: 04/27/2021
Onset Date: 04/27/2021
Rec V Date: 10/23/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Nausea, Pain in extremity, Pyrexia

Symptoms: Both arms sore; Back pain; Ringing in ears; Tiredness; This is a spontaneous report from a contactable consumer, the patient. A 52-year-old male patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP7533) via an unspecified route of administration in the left arm on 27Apr2021 at 09:30 (at the age of 52-years-old) as a single dose for COVID-19 immunisation. Medical history included obesity, high blood pressure and penicillin allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included amfetamine aspartate/amfetamine sulfate/dexamfetamine saccharate/dexamfetamine sulfate (ADDERALL XR), losartan potassium (LOSARTIN) and tamsulosin (MANUFACTURER UNKNOWN) all for an unknown indication from an unknown date and unknown if ongoing. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8733) via an unspecified route of administration in the left arm on 30Mar2021 at 09:30 (at the age of 51-years-old) as a single dose for COVID-19 immunisation. On 27Apr2021 at 15:00, the patient experienced both arms sore, back pain, ringing in ears and tiredness. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events both arms sore, back pain, ringing in ears and tiredness were not recovered at the time of reporting. No follow-up attempts are needed. No further information is expected.

Other Meds: ADDERALL; LOSARTIN; TAMSULOSIN

Current Illness:

ID: 1811698
Sex: F
Age:
State: FL

Vax Date: 04/01/2021
Onset Date: 04/23/2021
Rec V Date: 10/23/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: UNK
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Chills, Fatigue, Headache, Myalgia

Symptoms: Severe joint pain; Muscle pain; Red, swollen left arm; Red, swollen left arm; This is a spontaneous report from a contactable consumer, the patient. A 42-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0162) via an unspecified route of administration in the left arm on an unknown date in Apr2021 (at the age of 42-years-old) as a single dose for COVID-19 immunisation. Medical history included penicillin allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included cetirizine hydrochloride (ZYRTEC) and esomeprazole sodium (NEXIUM); both taken for an unknown indication from an unknown date and unknown if ongoing. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8730) via an unspecified route of administration in the left arm on 31Mar2021 at 13:00 (at the age of 42-years-old) as a single dose for COVID-19 immunisation. On 23Apr2021, after the second shot, the patient experienced severe joint and muscle pain for more than 4 days and red, swollen left arm. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events severe joint and muscle pain and red, swollen left arm was resolving at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: ZYRTEC [CETIRIZINE HYDROCHLORIDE]; NEXIUM [ESOMEPRAZOLE SODIUM]

Current Illness:

ID: 1811699
Sex: F
Age:
State: OR

Vax Date: 03/29/2021
Onset Date: 04/01/2021
Rec V Date: 10/23/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Headache, Heart rate increased, Injection site erythema, Injection site pain, Injection site swelling

Symptoms: Rash on right forearm that spread across trunk.; This is a spontaneous report from a contactable physician. A 53-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6201) via an intramuscular route of administration in the left arm on 29Mar2021 (at the age of 53-years-old) as a single dose for COVID-19 immunisation. Medical history included obesity, hyperlipidemia, vertigo, milk allergy . Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient previously took erythromycin (MANUFACTURER UNKNOWN) and experienced drug allergy. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6206) via an unspecified route of administration on 07Mar2021 (at the age of 53-years-old) as a single dose for COVID-19 immunisation. On 01Apr2021, the patient experienced rash on right forearm that spread across trunk. The event resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as a result of the event which included treatment with steroids (MANUFACTURER UNKNOWN) from an unknown start date to an unknown atop date. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event rash on right forearm that spread across trunk was not recovered at the time of report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1811700
Sex: F
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 10/23/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Nausea

Symptoms: Constipation; This is a spontaneous report from a non-contactable other healthcare professional, the patient. A 28-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8724) via an unspecified route of administration on an unknown date (at the age of 28-years-old) as a single dose for COVID-19 immunisation. Medical history included COVID-19 and known allergy to penicillins. Prior to the vaccination, the patient was diagnosed with COVID-19. Concomitant medications were not reported. On an unknown date, the patient experienced constipation. The event constipation did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the event. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event constipation was resolving at the time of this report. No follow-up attempts are possible. No further information is expected.

Other Meds:

Current Illness:

ID: 1811701
Sex: F
Age:
State: OH

Vax Date: 03/15/2021
Onset Date: 03/16/2021
Rec V Date: 10/23/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: UNK
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site pain

Symptoms: 14 DAYS AFTER 2ND VACCINE "I" HAVE VERTIGO; swelling of lymph nodes under left arm and neck for 5 days; Ringing in ears; This is a spontaneous report from a contactable other healthcare professional, the patient. A 62-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: en6208) via an unspecified route of administration in the left arm on 15Mar2021 at 17:15 (at the age of 62-year-old) as a single dose for COVID-19 immunisation. The patient did not have any medical history. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications were not reported. On 16Mar2021, the patient experienced swelling of lymph nodes under left arm, neck for 5 days and ringing in ears. On 30Mar2021, 14 days after second vaccine, the patient had vertigo. The adverse events did not result in doctor or other healthcare professional office or clinic visit and emergency room or department or urgent care. It was unknown whether therapeutic measures were taken as a result of the reported events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event swelling of lymph nodes under left arm and neck was recovered on 21Mar2021 after the duration of 5 days, while the events ringing in ears and vertigo were not recovered at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1811702
Sex: F
Age:
State: PA

Vax Date: 04/26/2021
Onset Date: 04/26/2021
Rec V Date: 10/23/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site induration, Injection site pruritus, Injection site swelling, Injection site warmth

Symptoms: She is weak; Her legs, her bones, everything hurts her; Her arm felt like it weighed 500 pounds where they put the shot in.; Her body was so tired; Caller states her head feels like its going to blow up; It feels like she has to go to the bathroom really bad, like number two, but she cant go; She cant concentrate to watch anything; Caller states she can't even stand up, she can't lay down, she can't do nothing; Can't watch TV, can't go on her iPad/she's all over the place, she's all over the bed like a crazy woman; She has a bad pain in her stomach, every joint hurts her; She has a bad pain in her stomach, every joint hurts her/ her knees, her ankles, the bones in her body and on her head feels like it's going to blow up; She has a fever; She loss her taste, she doesn't want to eat; She loss her taste, she doesn't want to eat), it means she is very ill/She is very sick; Caller states she's just in bed and she can't move.; She cant sleep; Her legs, her bones, everything hurts her; arm felt like it weighed 500 pounds where they put the shot in; she doesn't want to eat; This is a spontaneous report from a contactable consumer or other non hcp (Patient). A 64-years-old female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; formulation: Solution for injection Lot number: EW0171, Expiration date: Aug2021), via an unspecified route of administration at Arm Left on 26Apr2021 (at the age of 64-years-old) in the morning as a dose 2, single for COVID-19 immunisation. Medical history included ongoing gastrooesophageal reflux disease, ongoing back disorder, bunion operation, pancreatic carcinoma, surgery, mastectomy from an unknown date and unknown if ongoing. Concomitant medications included omeprazole (OMEPRAZOLE) taken for gastrooesophageal reflux disease, start and stop date were not reported, aspirin [acetylsalicylic acid] (ASPIRIN [ACETYLSALICYLIC ACID]) taken for an unspecified indication, start and stop date were not reported. it was reported that She did not take her flu shot since August or September of last year. Patient previously received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; formulation: Solution for injection, Lot number: ER8729, Expiration date: 31Jul2021), via an unspecified route of administration, administered in Arm Left on 31Jul2021 (at the age of 64-years-old) as dose 1, single for COVID-19 immunisation. Patients husband died a couple months ago and on 26Apr2021 patient had a bad pain in her stomach, every joint hurts her. It feels like she has to go to the bathroom really bad, like number two, but she cant go. She has a fever. Usually, if she has the flu, she can still go out. She's crazy, but nothing typically bothers her. So, for complain and stay in bed all day when it's in the 70s outside, and force herself to have a piece of toast, then she had Pepto-Bismol, a cup of tea, and made herself have soup (she loss her taste, she doesn't want to eat), it means she was very ill and she did not know how to get out of this. Reporter stated she did not know what to do, this was ridiculous. If she would have known this, she would have never gotten the vaccine. Patient just in bed and she can't move. She was 64 but people think she was 40. Everyone in her family looks real young, she has good genes. She stated she's crazy because she can't be held down for nothing. She could have fevers, flus, like she's had in the past and she would be up, moving around. It wouldn't bother her. she cannot sleep, she cannot watch tv, she cannot go on her iPad, She's all over the place. She's all over the bed like a crazy woman. She compares it to the secondhand dial on a watch- she just goes and is all over the place. Reporter stated that she made herself breakfast and she gave herself toast. About an hour ago she had Pepto-Bismol and then she made herself soup and she had to force it down. She loves this soup but she had to force it down and she did not eat it all. She cannot concentrate to watch anything. Her legs, her bones, everything hurts her. The patient had the second dose of the Pfizer covid 19 vaccine on 26Arp2021. Since then, she had excruciating bone pain and muscle pain. She cannot sleep, walk or do anything. She was using the heating pad, epsom salt baths, laying on the couch, taking advil and tylenol and 800 mg ibuprofen noting that nothing was helping. The patient took four hydrocodone and they did not help at all. It was constant pain and the achiness was worse than a toothache. She stated that she had heating pads across one side to the other side. She said that she then takes it down a little more to her legs. She said her hip and her knees, every bone and her side, her hip bones down the sides of her legs and her legs are hard to lift up. She said she usually walk every day but had not been able to walk. She said she was the crazy person that speed walks. She walked 12 miles one day. She states that she knows her doctor like a book and he wont be able to do anything because he was not familiar with the shot. She stated the pain was in her bones and her muscles. she stated that she cannot sleep or lay, she cannot walk, she cannot do anything. She stated that her doctor did not know about this and would not know what to do for her. She stated she had been trying to get pain pills, and she stated that even medical marijuanna did not help her back and muscle pain. She said that it was her bones and muscles, her hips bones and in her legs even. She said even hurts if she lays down. She said usually she was hyper and zingzang around. Now she tosses and turns on the couch with heating pads. She said that her her lower back, her hip muscles and in her legs even hurt. She states she fell down because the pain was so so bad. She said she missed two steps and smacked her head against the wall and broke her NINJA blender cup. She states she broke the damn thing. She states she just bought it too which she was more mad about then the pain. She said she had blood oh her head and the wall. She said her friend was behind her and tried to hold her back. She said her pain was just shooting in the upper area. She broke her ninja blender cup, the big one. She said she had a big thing on her head and blood on her head. She stated that it was the worst thing she ever did because after getting the second shot she had excruciating pain for two weeks. She states that it had been a couple weeks now and her daughter who was a compound pharmacist and made drugs said not to get the vaccine because it was too early. She stated she would go to the emergency room but what can they do for her and why should she pay for. Reporter stated the pain in her stomach was excruciating and stated her head feels like it's going to blow up. Reporter stated she cannot even stand up, she cannot lay down, she cannot do nothing. Reporter stated she had the shot at 0830 in the morning yesterday and she was good. Reporter stated around bedtime, she was not feeling right and then all night she was saying dear Jesus let her go to sleep. Reporter stated she took sleeping pills, she took everything, and nothing happened. She was hurting. Her stomach has terrible pain in it. Her knees, her ankles, the bones in her body and on her head felt like it was going to blow up. Her arm felt like it weighed 500 pounds where they put the shot in also states she would rather have triplets than what she had to go through yesterday. If she had to do it again, she never would have done it. Reporter stated she did not know what to do. She did not want to do anything. She cannot lay in bed. If she lays in bed, she's all over, the covers are all over the place. She was very sick. When probed for weight, she makes the comment she looks about 130 but she works out and she was all muscle, therefore she weighs 150lbs. Therapeutic measures were taken as a result of she has a bad pain in her stomach, every joint hurts her, she cant sleep , patient states her head feels like its going to blow up. Outcome of the events she has a bad pain in her stomach, every joint hurts, her knees, her ankles, the bones in her body and on her head feels like

Other Meds: OMEPRAZOLE; ASPIRIN [ACETYLSALICYLIC ACID]

Current Illness: Acid reflux (esophageal); Back disorder (Verbatim: back problems)

ID: 1811703
Sex: F
Age:
State: WI

Vax Date: 04/21/2021
Onset Date: 04/21/2021
Rec V Date: 10/23/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011j20a
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Chills, Dizziness, Nausea, Pain, Tachycardia

Symptoms: Difficult breathing night after shot; Feel very sick everyday- still lasting- can't do day to day things; Feel very sick everyday- still lasting- can't do day to day things; This is a spontaneous report from a contactable consumer, the patient. A 20-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 21Apr2021 at 15:00 (at the age of 20-years-old) as a single dose for COVID-19 immunisation. Medical history included asthma and fibromyalgia. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medication was not reported. The patient previously took amoxicillin; clavulanic acid (AUGMENTIN) and experienced drug allergy. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 21Apr2021 at 16:00, the patient felt difficult breathing night after shot and felt very sick everyday which was still lasting at the time of report and the patient could not do day to day things. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. No therapeutic measures were taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events felt difficult breathing night after shot, felt very sick everyday which was still lasting at the time of report and could not do day to day things was not resolved at the time of this report. No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds:

Current Illness:

ID: 1811704
Sex: M
Age:
State: PA

Vax Date: 04/26/2021
Onset Date: 04/27/2021
Rec V Date: 10/23/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Tremor

Symptoms: I had body aches and chills; I had body aches and chills; A massive migraine which caused nausea when any movements were made; A massive migraine which caused nausea when any movements were made; This is a spontaneous report from a contactable consumer, the patient. A 27-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0171) via an unspecified route of administration in the left arm on 26Apr2021 at 16:45 (at the age of 27-years-old) as a single dose for COVID-19 immunisation. Medical history included hypertension. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included metoprolol (MANUFACTURER UNKNOWN) and ibuprofen (MANUFACTURER UNKNOWN); both from an unknown date for an unknown indication and unknown if ongoing. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0150) via an unspecified route of administration in the left arm on 05Apr2021 at 17:15 (at the age of 27-years-old) as a single dose for COVID-19 immunisation. The patient previously took amoxicillin; clavulanic acid (AUGMENTIN) for unknown indication and experienced drug allergy. On 27Apr2021 at 06:00, the patient had body aches and chills, a massive migraine which caused nausea when any movements were made. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events he had body aches and chills and a massive migraine which caused nausea when any movements were made was recovered on an unknown date in Apr2021. No follow-up attempts are needed. No further information is expected.

Other Meds: METOPROLOL; IBUPROFEN

Current Illness:

ID: 1811705
Sex: F
Age:
State: GA

Vax Date: 04/27/2021
Onset Date: 04/28/2021
Rec V Date: 10/23/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Erythema, Pruritus

Symptoms: Fever; Chills; Muscle aches; Fatigue; Nausea; This is a spontaneous report from a contactable consumer, the patient. A 60-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8732) via an unspecified route of administration in the left arm on 27Apr2021 at 10:45 at the age of 60-years-old as a single dose for COVID-19 immunisation. The patient did not have any medical history. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included unspecified Multivitamin and VITAMIN C, taken for unknown indication from an unknown date and unknown if ongoing. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6198) via an unspecified route of administration in the left arm on 22Mar2021 at 09:45 at the age of 60-years-old as a single dose for COVID-19 immunisation. The patient previously took CODEINE for unknown indication and experienced drug allergy. On 28Apr2021 at 21:00, the patient experienced fever, chills, muscle aches, fatigue, and nausea. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events was fever, chills, muscle aches, fatigue, and nausea was resolving at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: VITAMIN C

Current Illness:

ID: 1811706
Sex: F
Age:
State:

Vax Date: 04/27/2021
Onset Date: 04/27/2021
Rec V Date: 10/23/2021
Hospital:

Vax Type: UNK
Manufacturer: UNKNOWN MANUFACTURER
Vax Name: VACCINE NOT SPECIFIED (NO BRAND NAME)
Lot:
Dose Series: UNK
Vax Route: SYR
Vax Site: UN

Lab Data:

Allergies:

Symptom List: Injection site erythema, Injection site induration, Injection site pruritus, Injection site swelling, Myalgia

Symptoms: Nausea, fever and chills; Fever; Chills; This is a spontaneous report from a non-contactable consumer, the patient. A 39-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0172) via an unspecified route of administration in the left arm on 27Apr2021 at 07:30 (at the age of 39-year-old), as a single dose for COVID-19 immunisation. Medical history included immune thrombocytopenic purpura. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. Concomitant medications were not reported. The patient previously received erythromycin (MANUFACTURER UNKNOWN) for unspecified indication from unknown date and experienced drug allergy and received first dose of BNT162b2(PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8737) via an unspecified route of administration in the left arm on 05Apr2021 at 07:30 (at the age of 39-year-old), as a single dose for COVID-19 immunisation. On 27Apr2021 at 18:00, the patient experienced nausea, fever and chills. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event nausea, fever and chills was resolving at the time of this report. No follow-up attempts are possible. No further information is expected.

Other Meds:

Current Illness:

ID: 1811707
Sex: M
Age:
State: IL

Vax Date: 04/27/2021
Onset Date: 04/27/2021
Rec V Date: 10/23/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Cough, Limb discomfort, Pain, SARS-CoV-2 test positive

Symptoms: Shortness of breath; Chills; Fever; Muscle aches all over; Weak body; Arm pain; Diarrhea; Nauseous; Haven't wanted to eat in over 13 hours when symptoms began; Severe headaches; This is a spontaneous report from a contactable consumer, the patient. A 32-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 27Apr2021 at 07:15 (at the age of 32-years-old) as a single dose for COVID-19 immunisation. Medical history included patient was obese. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications taken within two weeks of vaccination included lisinopril (MANUFACTURER UNKNOWN), emtricitabine, tenofovir disoproxil fumarate (TRUVADA) and topiramate (MANUFACTURER UNKNOWN); all from unknown date for unknown indication and unknown if ongoing. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on an unknown date as a single dose for COVID-19 immunisation. The patient previously took cefixime (MANUFACTURER UNKNOWN), phenytoin sodium (MANUFACTURER UNKNOWN), vancomycin (MANUFACTURER UNKNOWN), fosphenytoin sodium (MANUFACTURER UNKNOWN) and possibly experienced drug allergy but it was unknown. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 27Apr2021 at 17:30, the patient experienced shortness of breath, chills, fever, muscle aches all over, weak body, arm pain, diarrhea, felt nauseous, the patient didn't want to eat and had severe headaches. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events shortness of breath, chills, fever, muscle aches all over, weak body, arm pain, diarrhea, felt nauseous, the patient didn't want to eat and had severe headaches was not resolved at the time of this report. No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds: LISINOPRIL; TRUVADA; TOPIRAMATE

Current Illness:

ID: 1811709
Sex: F
Age:
State: OH

Vax Date: 03/23/2021
Onset Date: 04/14/2021
Rec V Date: 10/23/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Asthenia, Chills, Headache, Myalgia

Symptoms: Very swollen gland above collar bone on left side. It has been over 2 weeks since "I" received the second dose of the vaccine and my gland is still swollen; This is a spontaneous report from a contactable consumer, the patient. A 49-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8734) via an unspecified route of administration in the left arm on 23Mar2021 (at the age of 49-years-old) as a single dose for COVID-19 immunisation. Medical history included high cholesterol. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included metformin (MANUFACTURER UNKNOWN), atorvastatin (MANUFACTURER UNKNOWN) and duloxetine (MANUFACTURER UNKNOWN); all for an unknown indication from an unknown date and unknown if ongoing. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP7534) via an unspecified route of administration in the left arm on an unknown date as a single dose for COVID-19 immunisation. On 14Apr2021, the patient had very swollen gland above collar bone on the left side that had been over 2 weeks since the patient received second dose of vaccination and her gland was still swollen (when reported by the patient). The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events very swollen gland above collar bone on the left side was not resolved at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: METFORMIN; ATORVASTATIN; DULOXETINE

Current Illness:

ID: 1811710
Sex: F
Age:
State: NY

Vax Date: 04/27/2021
Onset Date: 04/27/2021
Rec V Date: 10/23/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site erythema, Injection site pain, Injection site swelling

Symptoms: Brain fog started within 5 hrs of injection; Confusion started within 5 hrs of injection; Terrible headache started overnight following injection; Extreme fatigue; This is a spontaneous report from a contactable consumer, the patient. A 44-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 27Apr2021 at 10:00 (at the age of 44-years-old) as a single dose for COVID-19 immunisation. Medical history included covid-19 (Prior to vaccination, the patient was diagnosed with COVID-19). The patient had no known allergies. The patient did not take any concomitant medications within 2 weeks of vaccination. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 05Apr2021 at 10:00 (at the age of 43-years-old) as a single dose for COVID-19 immunisation. On 27Apr2021 at 15:00, the patient experienced brain fog and confusion started within 5 hours of injection, terrible headache started overnight following injection and extreme fatigue. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events foggy feeling in head, confusion, headache and fatigue extreme was not resolved at the time of report. No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds:

Current Illness:

ID: 1811711
Sex: M
Age:
State: TX

Vax Date: 04/05/2021
Onset Date: 04/06/2021
Rec V Date: 10/23/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot: EK9231
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Chills, Feeling cold, Feeling hot, Myalgia, Pain

Symptoms: Loud persistent ringing in left ear (tinnitus) occurred early the next morning in combination with chills, aches, pain throughout the night; Loud persistent ringing in left ear (tinnitus) occurred early the next morning in combination with chills, aches, pain throughout the night.; Loud persistent ringing in left ear (tinnitus) occurred early the next morning in combination with chills, aches, pain throughout the night.; This is a spontaneous report from a contactable consumer, the patient. A 50-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8733) via an unspecified route of administration in the left arm on 05Apr2021 at 09:30 (at the age of 50-years-old) as a single dose for COVID-19 immunisation. The patient had no medical history. The patient had no known allergies. The patient did not take any concomitant medications. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 06Apr2021 at 04:00, the patient experienced loud persistent ringing in left ear (tinnitus) occurred early the next morning in combination with chills, aches, pain throughout the night. Ringing has continued for several weeks and shows no sign of subsiding. The events resulted in doctor or other healthcare professional office/clinic visit. The patient did not receive any treatment for the events. The clinical outcome of the events loud persistent ringing in left ear (tinnitus) occurred early the next morning in combination with chills, aches, pain throughout the night were not recovered at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1811712
Sex: F
Age:
State: FL

Vax Date: 02/19/2021
Onset Date: 02/19/2021
Rec V Date: 10/23/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Pain in extremity

Symptoms: Where i received my injection my arm is still sore whenever I move it it feels like its in my muscle; This is a spontaneous report from a contactable consumer, the patient. A 70-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 19Feb2021 at 09:00 (at the age of 70-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any medication within two weeks of vaccination. The patient did not receive any other vaccines within four weeks prior to the vaccination. Where the patient received her injection, her arm was still sore on 19Feb2021 at 23:00, whenever she moved it, it felt like it's in her muscle. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event where the patient received her injection arm was still sore whenever she moved it, it felt like it's in her muscle was not resolved at the time of this report. No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds:

Current Illness:

ID: 1811713
Sex: M
Age:
State: NJ

Vax Date: 04/26/2021
Onset Date: 04/27/2021
Rec V Date: 10/23/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 2
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Abdominal pain upper, Abnormal behaviour, Adverse reaction, Anger, Asthma

Symptoms: Have experienced shortness of breath; Increased wheezing; Headaches; This is a spontaneous report from a contactable consumer, the patient. A 23-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 26Apr2021 at 13:00 (at the age of 23-years-old) as a single dose for COVID-19 immunisation. Medical history included asthma from an unknown date and unknown if ongoing. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included salbutamol (VENTOLIN) and fexofenadine hydrochloride (ALLEGRA); for unknown indications, from an unknown date and unknown if ongoing. The patient previously took azithromycin (MANUFACTURER UNKNOWN) on unknown date for unknown indication and experienced drug allergy. The patient did not receive any other vaccine within four weeks prior to the COVID-19 vaccine. On 27Apr2021 at 12:00, the patient experienced shortness of breath, increased wheezing and headaches. The patient did not see shortness of breath on the side effects so he wanted to make it noted. The events did not result in doctor or other healthcare professional office/clinic, emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were not taken as a result of the reported events. The clinical outcome of the events shortness of breath, increased wheezing and headaches was recovering at the time of this report. No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds: VENTOLIN [SALBUTAMOL]; ALLEGRA

Current Illness:

ID: 1811714
Sex: F
Age:
State:

Vax Date: 04/07/2021
Onset Date: 04/01/2021
Rec V Date: 10/23/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data: Test Date: 202008; Test Name: Nasal swab; Test Result: Negative

Allergies:

Symptom List: Consciousness fluctuating, Crying, Dry skin, Epistaxis, Headache

Symptoms: Period came 7 days early; I had PMS symptoms much worse than I usually get; Bloating; Overly emotional; Terrible cramps/ soreness; Terrible cramps/ soreness; This is a spontaneous report from a non-contactable consumer, the patient. A 32-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP7534) via an unspecified route of administration in the right arm on 07Apr2021 at 18:00 (at the age of 32-year-old), as a single dose for COVID-19 immunisation. Medical history was not reported. The patient had no known allergies. On an unknown date in Aug2020, the patient underwent COVID-19 test via nasal swab and the result was negative. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. Concomitant medications included spironolactone (MANUFACTURER UNKNOWN) 50mg, melatonin (MANUFACTURER UNKNOWN) 5mg and vitamin D NOS (MANUFACTURER UNKNOWN); all for unknown indications from an unknown date and unknown if ongoing. On 16Apr2021, the patient's period came 7 days early. The week prior to that, the patient experienced premenstrual syndrome (PMS) symptoms much worse than she usually got: overly emotional, bloating, terrible cramps and soreness. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events period came 7 days early, PMS symptoms much worse than she usually got: overly emotional, bloating, terrible cramps, soreness was resolved on an unspecified date in Apr2021. No follow-up attempts are possible. No further information is expected.

Other Meds: SPIRONOLACTONE; MELATONIN; VITAMIN D NOS

Current Illness:

ID: 1811715
Sex: F
Age:
State: PA

Vax Date: 04/27/2021
Onset Date: 04/27/2021
Rec V Date: 10/23/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Hypotonia, Lethargy, Respiratory rate decreased, Screaming, Skin warm

Symptoms: Tingling in right leg-whole leg; Leg also feels heavy and weak; Leg also feels heavy and weak; Left temporal headache; Confusion; This is a spontaneous report from a contactable consumer, the patient. A 42-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0172) via an unspecified route of administration in the left arm on 27Apr2021 at 15:15 (at the age of 42-years-old) as a single dose for COVID-19 immunisation. Medical history included REM sleep behavior disorder (RBD) sleep disorder, attention deficit hyperactivity disorder (ADHD) and chronic sinusitis. The patient had known allergies to shellfish and sulfa. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included sertraline (MANUFACTURER UNKNOWN) and clonazepam (MANUFACTURER UNKNOWN); both taken for unknown indications from an unknown date and unknown if ongoing. The patient previously took ondansetron (ZOFRAN), metoclopramide (REGLAN) and lamotrigine (LAMICTAL); all for unknown indications and experienced drug allergy. On 27Apr2021 at 15:45, the patient experienced tingling in right leg-whole leg, leg also felt heavy and weak, left temporal headache and confusion. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. It was unknown whether any therapeutic measures were taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events tingling in right leg-whole leg, leg also feels heavy and weak, left temporal headache and confusion was not resolved at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: SERTRALINE; CLONAZEPAM

Current Illness:

ID: 1811716
Sex: F
Age:
State: PA

Vax Date: 04/16/2021
Onset Date: 04/16/2021
Rec V Date: 10/23/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 026LZOA
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Vomiting

Symptoms: Continuous migraine; Fatigue; Neck pain; Remittent chest pain; Burning back; This is a spontaneous report from a contactable consumer, the patient. A 28-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0164) via an unspecified route of administration in the arm left on 16Apr2021 at 13:45 (at the age of 28-years-old) as a single dose for COVID-19 immunisation. Medical history included interstitial cystitis, endometriosis, penicillin allergy, meat allergy (beef, pork, poultry), egg allergy and milk allergy (diary). Prior to the vaccination, the patient was diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included cetirizine hydrochloride (ZYRTEC), montelukast sodium (SINGULAIR), amitriptyline (MANUFACTURER UNKNOWN) and hyoscyamine sulfate, methenamine, methylthioninium chloride, phenyl salicylate, phosphoric acid sodium (URIBEL) all were taken for unknown indication from an unknown date and unknown if ongoing. On 16Apr2021 at 14:45, the patient experienced continuous migraine, fatigue and neck pain since the vaccine date every day for two weeks, still going strong. Remittent chest pain since then as well. Burning back, chest pain, migraine, neck pain, and fatigue began about an hour after receiving the vaccine. The events resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were not taken as a result of events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events continuous migraine, fatigue, neck pain, remittent chest pain and burning back were not recovered at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: ZYRTEC [CETIRIZINE HYDROCHLORIDE]; SINGULAIR; AMITRIPTYLINE; URIBEL

Current Illness:

ID: 1811717
Sex: F
Age:
State: MA

Vax Date: 04/22/2021
Onset Date: 04/28/2021
Rec V Date: 10/23/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 037K20A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Headache, Limb discomfort, Nasal congestion

Symptoms: Period or menstruated out of cycle; This is a spontaneous report from a non-contactable consumer, the patient. A 34-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on 22Apr2021 at 10:30 (at the age of 34-years-old) as a single dose for COVID-19 immunisation. Medical history included penicillin allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not take any concomitant medications within 2 weeks of vaccination. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 28Apr2021 at 09:00 the patient experienced period or menstruated out of cycle. The event did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the event. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event period or menstruated out of cycle was not resolved at the time of this report. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds:

Current Illness:

ID: 1811718
Sex: M
Age:
State: NJ

Vax Date: 03/25/2021
Onset Date: 03/26/2021
Rec V Date: 10/23/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Back pain, Cold sweat, Headache, Nausea, Vomiting

Symptoms: Moderate blurry vision / haze; Moderate blurry vision / haze; Eyes feel strained.; This is a spontaneous report from a contactable consumer, the patient. A 43-year-old male patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8730) in the left arm on 25Mar2021 at 09:30 (at the age of 43-years-old) and also received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0171) in the left arm on 22Apr2021 at 09:15 (at the age of 43-years-old) as a dose for COVID-19 immunisation. Medical history included left eye cornea injury when patient was 12 or 13, that inhibits focus and gives a haze on left eye only. Right eye has always compensated and given perfect vision and color representation. One of patient's professions is as graphic designer and over past two years patient's close vision has slowly decreased due to age. The patient has known allergies to penicillin. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included pantoprazole (MANUFACTURER UNKNOWN); for unknown indications from an unknown date and unknown if ongoing. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. On 26Mar2021, the patient experienced moderate blurry vision/haze which started after first dose. No distance range was in perfect focus, eyes felt strained and it seemed to be getting worse every day. The patient reported that these new issues were not related to his previous medical history of eye cornea injury. The events resulted in doctor or other healthcare professional office/clinic visit. It was unknown whether any therapeutic measures were taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events blurry vision/haze and eyes felt strained were not recovered at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: PANTOPRAZOLE

Current Illness:

ID: 1811719
Sex: F
Age:
State: VA

Vax Date: 02/24/2021
Onset Date: 03/17/2021
Rec V Date: 10/23/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025j20-2A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site swelling, Limb discomfort

Symptoms: Chronic mild nosebleed; Cough; Axillary lymph node pain; This is a spontaneous report from a contactable healthcare professional, the patient. A 22-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via intramuscular route of administration in the left arm on 24Feb2021 at 16:00(at the age of 22-years-old) as a single dose for COVID-19 immunisation. Medical history included hyperhomocysteinemia, anxiety and ADHD. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient did not receive other vaccines within four weeks prior to the vaccination. Concomitant medications included escitalopram oxalate (LEXAPRO), amfetamine aspartate, amfetamine sulfate, dexamfetamine saccharate, dexamfetamine sulfate (ADDERALL) and doxycycline (MANUFACTURER UNKNOWN); all for unknown indication from unknown date and unknown if ongoing. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via intramuscular route of administration in the left arm on 03Feb2021 at 16:00(at the age of 22-years-old) as a single dose for COVID-19 immunisation. On 17Mar2021 the patient experienced chronic mild nose bleed, cough and axillary lymph node pain. The events resulted in doctor or other health care professional office/clinic visit. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events chronic mild nose bleed, cough, axillary lymph node pain was recovered with sequelae on an unknown date in 2021. No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds: LEXAPRO; ADDERALL; DOXYCYCLINE

Current Illness:

ID: 1811720
Sex: M
Age:
State:

Vax Date: 04/26/2021
Onset Date: 04/26/2021
Rec V Date: 10/23/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Chills, Diarrhoea, Fatigue, Feeling abnormal, Headache

Symptoms: Tightness in the chest area and feels heavier; This is a spontaneous report from a non-contactable consumer, the patient. A 46-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 26Apr2021 at 12:00 (at the age of 46-years-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to vaccination. On 26Apr2021, the patient experienced tightness in the chest area and felt heavier. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events tightness in the chest area and felt heavier was not resolved at the time of this report. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds:

Current Illness:

ID: 1811721
Sex: F
Age:
State:

Vax Date: 04/03/2021
Onset Date: 04/03/2021
Rec V Date: 10/23/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 037K20A
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data: Test Date: 20210410; Test Name: SARS-CoV-2 test; Test Result: Negative ; Comments: Nasal Swab

Allergies:

Symptom List: Hot flush, Myalgia, Nausea, Tension headache

Symptoms: Severe menstrual cramps; Fever; Chills; Muscle/joint aches in legs; Muscle/joint aches in legs; Headache; Tiredness; This is a spontaneous report from a non-contactable consumer, the patient. An 18-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8729) via an unspecified route of administration in the right arm on 03Apr2021 at 11:15 (at the age of 18-year-old) as a single dose for COVID-19 immunisation. The patient had no medical history. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included isotretinoin (MANUFACTURER UNKNOWN); on an unknown date, for unknown indication and unknown if ongoing. The patient previously took first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6207) via an unspecified route of administration in the right arm on an unknown date in Mar2021 at 15:00 (at the age of 18-years-old) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 03Apr2021 at 21:30, the patient experienced severe menstrual cramps, fever, chills, muscle/joint aches in legs, headache and tiredness. Since the vaccination, on 10Apr2021, the patient underwent nasal swab SARS-CoV-2 test and the result was negative. The clinical outcome of the events severe menstrual cramps, fever, chills, muscle/joint aches in legs, muscle/joint aches in legs, muscle/joint aches in legs, headache and tiredness was recovered on an unknown date in Apr2021. No follow-up attempts are possible. No further information is expected.

Other Meds: ISOTRETINOIN

Current Illness:

Total 2021 VAERS Injuries: 654,986

Page last modified: 13 November 2021 9:17am